Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Accepted on 20 Jun 2025

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to SARS-CoV-2 RBD subunit vaccine

in Vaccines and Molecular Therapeutics

João Pedro da Silva Nunes
Mariângela Silva
Juliana Apostolico
Isabela Pazotti Daher
Rodolfo Ferreira Marques
Marcio Massao Yamamoto
Alexia Adrianne Venceslau Brito Carvalho
Maria Fernanda de Castro Amarante
Edison Luiz Durigon
Carsten Wrenger

Frontiers in Immunology

doi 10.3389/fimmu.2025.1610422

Original Research

Published on 20 Jun 2025

Comparison of homologous and heterologous vaccination strategies for combating disease caused by Burkholderia pseudomallei

in Vaccines and Molecular Therapeutics

Sergei S. Biryukov
Christopher K. Cote
Christopher P. Klimko
Jennifer L. Dankmeyer
Nathaniel O. Rill
Melissa Hunter
Michael L. Davies
Zander M. Hedrick
Jennifer L. Shoe
Lindsey K. Schmidt

Frontiers in Immunology

doi 10.3389/fimmu.2025.1596265

145 views

Original Research

Published on 20 Jun 2025

GMMA-based vaccine candidates against invasive nontyphoidal salmonellosis elicit bactericidal antibodies against a panel of epidemiologically relevant Salmonellae

in Vaccines and Molecular Therapeutics

Daniele De Simone
Marika Pinto
Maria Grazia Aruta
Marta Benincasa
Martina Carducci
Roberta Di Benedetto
Francesco Citiulo
Miren Iturriza
Elli Mylona
Stephen Baker

Frontiers in Immunology

doi 10.3389/fimmu.2025.1610067

215 views

Correction

Published on 19 Jun 2025

Correction: Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

in Vaccines and Molecular Therapeutics

Yanan Tong
Guoxiu Lu
Zhiguo Wang
Shanhu Hao
Guoxu Zhang
Hongwu Sun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1639717

130 views

Original Research

Published on 19 Jun 2025

Circular mRNA-LNP vaccine encoding self-assembled E2-TMD-mi3 nanoparticles licit enhanced CSFV-specific immunity over commercial subunit vaccine

in Vaccines and Molecular Therapeutics

Chunxi Liu
Weifeng Zhai
Wenhao Nie
Conghao Zhong
Feifei Diao
Bo Yin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1604677

308 views

Perspective

Published on 18 Jun 2025

Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors

in Vaccines and Molecular Therapeutics

Montserrat Puig
Sophie Shubow

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608401

507 views

Original Research

Published on 18 Jun 2025

Epidemiological characteristics of breakthrough varicella cases among students in Jiulongpo District, Chongqing: implications for vaccination strategies

in Vaccines and Molecular Therapeutics

Huixian Zhou
Qianjin Long
Hechuan Xie
Yuan Yao
Chunyan Deng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1594598

226 views

Editorial

Published on 17 Jun 2025

Editorial: Nanoparticle-based delivery systems on immunomodulation

in Vaccines and Molecular Therapeutics

Pedro Augusto Carvalho Costa
Pedro Pires Goulart Guimaraes

Frontiers in Immunology

doi 10.3389/fimmu.2025.1626027

399 views

Correction

Accepted on 16 Jun 2025

Corrigendum: Development of a subunit vaccine against the cholangiocarcinoma causing Opisthorchis viverrini: a computational approach

in Vaccines and Molecular Therapeutics

Mohibullah Shah

Frontiers in Immunology

doi 10.3389/fimmu.2025.1638914

Original Research

Accepted on 16 Jun 2025

Integrating Bioinformatics to Explore HPV-31 and HPV-52 E6/E7 Proteins: From Structural Analysis to Antigenic Epitope Prediction

in Vaccines and Molecular Therapeutics

Qixue Cai
Yifan Feng
Wenbo Dong
Yanling Meng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1561572

Original Research

Accepted on 16 Jun 2025

PepSeq as a highly multiplexed platform for melioidosis antigen discovery and vaccine development

in Vaccines and Molecular Therapeutics

Evan A Elko
Charles Williamson
Heather R Green
Marcellene A Gates-Hollingsworth
Georgia A. Nelson
Sujata G Pandit
Heather Mead
Christopher Allender
Celeste Woerle
Mark John Mayo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1605758

115 views

Original Research

Accepted on 16 Jun 2025

Dynamics of HBsAb Persistence and Associated BCR IgG-H CDR3 Repertoire Features in Ultra-High versus Extremely Low Responders to HBV Vaccination

in Vaccines and Molecular Therapeutics

Xinsheng Yao
Tingwen Yang
Lina Sun
Ting Zhang
Yurong Pan
Jun Li
Yangyang Li
Zhiyong Han
Wanbang Sun
Xiaoyan He

Frontiers in Immunology

doi 10.3389/fimmu.2025.1587553

Original Research

Published on 16 Jun 2025

A novel and safe SmartCap® SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans

in Vaccines and Molecular Therapeutics

Rachel Kim
Tae-Gi Uhm
Jisu Kim
Dayeon Woo
Uk-Il Kim
Xue Meng
Byounggu Yang
Suhyeon Kim
Heejene Kim
Jonghyeon Kim

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571092

1,029 views

Review

Published on 16 Jun 2025

Immune responses to human papillomavirus infection and vaccination

in Vaccines and Molecular Therapeutics

Eunice Wavinya Kiamba
Martin R. Goodier
Ed Clarke

Frontiers in Immunology

doi 10.3389/fimmu.2025.1591297

379 views

Original Research

Accepted on 14 Jun 2025

Immuno-informatics Analyses of Important Esophageal Cancer (EC) Associated Viruses for Multi-Epitope Vaccine Design

in Vaccines and Molecular Therapeutics

Zafer Saad Al Shehri

Frontiers in Immunology

doi 10.3389/fimmu.2025.1587224

205 views

Review

Published on 12 Jun 2025

T cells responses after vaccination: a regulatory perspective

in Vaccines and Molecular Therapeutics

Alessandra Buoninfante
Marco Cavaleri

Frontiers in Immunology

doi 10.3389/fimmu.2025.1584738

645 views